What We're Reading: Page 283
Industry reads hand-picked by our editors
Nov 01, 2017
Oct 31, 2017
-
The Wall Street Journal
Novo Nordisk, facing pricing pressure, branches out beyond insulin
-
TheStreet
OptiNose gears up for a big year
-
Reuters
Investor group presses U.S. drug companies on opioid controls
Oct 30, 2017
Oct 27, 2017
Oct 26, 2017
-
Bloomberg
The wonder drug for aging (made from one of the deadliest toxins on Earth)
-
Vox
2 new CRISPR tools overcome the scariest parts of gene editing
-
Boston Business Journal
MGH researcher develops promising Alzheimer's drug
-
Gizmodo
When hope runs out, cancer patients are making their own DIY immunotherapy treatments
Oct 25, 2017
-
Retail Dive
Walgreens sales remain 'anemic' despite Rite Aid takeover
-
MIT Technology Review
Tracking the cost of gene therapy
-
MobiHealthNews
Bracket acquires mProve Health, doubles-down on mobile-supported clinical trials
-
Technology Networks
The role of phenotypic screening in drug discovery
Previous
